Biological foundations of behavior and mental processes. Covers brain structure and function (cerebral cortex, limbic system, brainstem, cerebellum, lateralization), neurotransmitter systems (dopamine, serotonin, norepinephrine, GABA, glutamate, acetylcholine), neural plasticity (synaptic plasticity, neurogenesis, critical periods, experience-dependent change), and psychopharmacology (drug mechanisms, tolerance, dependence, major drug classes). Use when analyzing brain-behavior relationships, neurotransmitter function, neural development and plasticity, or pharmacological effects on cognition and behavior.
Behavioral neuroscience (also called biological psychology or psychobiology) studies the biological substrates of behavior and mental processes. The central premise is that every psychological phenomenon -- perception, memory, emotion, decision-making, personality, psychopathology -- has a neural basis. This does not mean psychology is reducible to neuroscience; rather, understanding the brain constrains and enriches psychological theory. The field draws on neuroanatomy, neurophysiology, neurochemistry, genetics, and pharmacology.
Agent affinity: james (mind-body relationship, pragmatic integration of biological and psychological levels), kahneman (neural basis of dual-process cognition)
Concept IDs: psych-brain-structure, psych-stress-response, psych-theories-of-emotion, psych-learning-theory
| # | Domain | Core Question | Key Methods |
|---|---|---|---|
| 1 | Brain structure | What does each brain region do? | Lesion studies, neuroimaging (fMRI, PET, CT), electrical stimulation |
| 2 |
| Neurotransmitters |
| How do chemical messengers modulate behavior? |
| Pharmacological manipulation, receptor binding, microdialysis |
| 3 | Neural plasticity | How does the brain change with experience? | Long-term potentiation, neurogenesis studies, critical period research |
| 4 | Psychopharmacology | How do drugs alter brain function and behavior? | Clinical trials, dose-response studies, receptor affinity profiling |
The brain is organized both hierarchically (brainstem handles basic survival, cortex handles higher cognition) and laterally (left hemisphere is typically dominant for language, right for spatial processing and emotional prosody). Damage at any level produces specific, predictable deficits.
Cerebral cortex. The wrinkled outer layer, ~2-4 mm thick, containing roughly 16 billion neurons. Divided into four lobes:
| Lobe | Location | Primary functions | Key areas |
|---|---|---|---|
| Frontal | Front | Planning, decision-making, voluntary movement, personality, working memory | Primary motor cortex (M1), prefrontal cortex (PFC), Broca's area |
| Parietal | Top-back | Somatosensory processing, spatial awareness, attention | Primary somatosensory cortex (S1), posterior parietal cortex |
| Temporal | Sides | Auditory processing, language comprehension, memory, object recognition | Primary auditory cortex (A1), Wernicke's area, fusiform face area |
| Occipital | Back | Visual processing | Primary visual cortex (V1), V2-V5 visual association areas |
Prefrontal cortex (PFC). The most anterior part of the frontal lobe. Critical for executive functions: planning, inhibition, working memory, cognitive flexibility, and social behavior. The case of Phineas Gage (1848) -- an iron rod through his left frontal lobe transformed a responsible foreman into an impulsive, socially inappropriate man -- provided early evidence for PFC's role in personality and self-regulation.
Limbic system. A circuit of interconnected structures deep within the brain:
Basal ganglia. Subcortical nuclei (caudate, putamen, globus pallidus) involved in motor control, procedural learning, and reward processing. Degeneration of dopaminergic neurons in the substantia nigra causes Parkinson's disease (tremor, rigidity, bradykinesia).
Cerebellum. "Little brain" at the posterior base. Coordinates voluntary movement, balance, motor learning, and (increasingly recognized) cognitive functions including timing, prediction, and language processing. Contains more neurons than the rest of the brain combined.
Brainstem. Midbrain, pons, and medulla. Controls vital functions: breathing, heart rate, sleep-wake cycles, arousal. The reticular activating system (RAS) in the brainstem regulates overall cortical arousal.
Split-brain studies (Sperry, 1968; Gazzaniga, 1967) in patients with severed corpus callosum revealed that the two hemispheres can operate independently, each with its own perceptions, memories, and even personality traits.
Neurotransmitters are chemical messengers released at synapses. They bind to receptors on the postsynaptic neuron, producing excitatory or inhibitory effects. The same neurotransmitter can have different effects at different receptor subtypes.
| Neurotransmitter | Primary role | Imbalance associated with | Key pathways |
|---|---|---|---|
| Dopamine | Reward, motivation, motor control, working memory | Schizophrenia (excess in mesolimbic), Parkinson's (deficit in nigrostriatal), addiction | Mesolimbic (reward), mesocortical (cognition), nigrostriatal (motor) |
| Serotonin (5-HT) | Mood regulation, sleep, appetite, impulse control | Depression, anxiety, OCD | Raphe nuclei to widespread cortical and limbic targets |
| Norepinephrine (NE) | Arousal, attention, fight-or-flight, mood | Depression (deficit), PTSD (excess), ADHD | Locus coeruleus to cortex, limbic system, brainstem |
| GABA | Primary inhibitory neurotransmitter, calming | Anxiety (deficit), epilepsy (deficit) | Widespread inhibitory interneurons throughout the brain |
| Glutamate | Primary excitatory neurotransmitter, learning, memory | Excitotoxicity in stroke, neurodegeneration | Widespread excitatory projections, NMDA receptors critical for LTP |
| Acetylcholine (ACh) | Attention, memory, muscle contraction | Alzheimer's disease (deficit in basal forebrain cholinergic system) | Basal forebrain to cortex, neuromuscular junction |
The sequence: (1) action potential reaches axon terminal, (2) calcium influx triggers vesicle fusion, (3) neurotransmitter released into synaptic cleft, (4) binds postsynaptic receptors, (5) produces excitatory or inhibitory postsynaptic potential, (6) terminated by reuptake, enzymatic degradation, or diffusion.
Drugs alter behavior by modifying this process: agonists enhance transmission (by mimicking, increasing release, or blocking reuptake), antagonists reduce it (by blocking receptors or inhibiting release).
The brain is not hard-wired. It changes structurally and functionally in response to experience, injury, and development. Plasticity is the biological basis of learning, memory, and recovery from brain damage.
Long-term potentiation (LTP). Bliss and Lomo (1973) discovered that brief high-frequency stimulation of a neural pathway produces a long-lasting increase in synaptic strength. LTP at hippocampal synapses requires NMDA receptor activation and is widely regarded as a cellular mechanism of learning and memory. The key properties -- input specificity, associativity, and cooperativity -- map onto the properties of associative learning.
Long-term depression (LTD). The complementary process: low-frequency stimulation produces a long-lasting decrease in synaptic strength. LTD enables forgetting and the weakening of unused connections, preventing saturation.
New neurons are generated in the adult brain, primarily in the hippocampal dentate gyrus and the subventricular zone (Eriksson et al., 1998). Adult hippocampal neurogenesis is enhanced by exercise, enriched environments, and learning, and suppressed by stress and depression. Its functional significance is debated but likely involves pattern separation in memory.
Hubel and Wiesel (1962) showed that monocular deprivation during a critical period in kitten development permanently altered visual cortex organization. The deprived eye lost cortical territory to the open eye (ocular dominance plasticity). Critical periods exist for language acquisition, binocular vision, and emotional attachment. After the critical period closes, the same experience produces much weaker plastic change.
The brain's structure reflects its owner's experience:
| Mechanism | Effect | Example |
|---|---|---|
| Receptor agonist | Mimics neurotransmitter at receptor | Nicotine at ACh receptors |
| Receptor antagonist | Blocks receptor without activating it | Haloperidol at D2 receptors |
| Reuptake inhibitor | Blocks reuptake transporter, increasing synaptic concentration | Fluoxetine (Prozac) at serotonin transporter |
| Release enhancer | Increases neurotransmitter release from presynaptic terminal | Amphetamine reverses dopamine transporter |
| Enzyme inhibitor | Blocks enzymatic degradation of neurotransmitter | MAOIs block monoamine oxidase |
| Allosteric modulator | Enhances or reduces receptor response to neurotransmitter | Benzodiazepines at GABA-A receptor |
| Class | Examples | Mechanism | Psychological effects |
|---|---|---|---|
| Stimulants | Amphetamine, cocaine, caffeine, nicotine | Increase catecholamine activity | Alertness, euphoria, reduced appetite, anxiety at high doses |
| Depressants | Alcohol, benzodiazepines, barbiturates | Enhance GABA / reduce glutamate | Relaxation, disinhibition, sedation, amnesia |
| Opioids | Morphine, heroin, fentanyl | Agonists at mu-opioid receptors | Analgesia, euphoria, respiratory depression |
| Hallucinogens | LSD, psilocybin, mescaline | 5-HT2A receptor agonists | Altered perception, synesthesia, mystical experiences |
| Cannabis | THC, CBD | Cannabinoid CB1/CB2 receptor agonists | Relaxation, altered time perception, memory impairment, anxiolysis |